Independent Review (PBS)

The circumstances allowing for an independent review

Page last updated: 1 November 2010

Independent review is available where the Pharmaceutical Benefits Advisory Committee (PBAC) has declined to recommend the listing of a drug on the Pharmaceutical Benefits Scheme (PBS), or in certain circumstances where the PBAC has not recommended the extension of the listing of a PBS item for an additional indication. 

Further information on the independent review is available at the Independent Review (PBS)  website.